Vibegron Under Review for Men With OAB Symptoms Receiving BPH Treatment

The FDA has accepted the sNDA for vibegron for the treatment of men with overactive bladder symptoms receiving drug therapy for BPH.

Related Keywords

Tsutomu Nakagawa ,Sumitomo Pharma America Inc ,International Prostate Symptoms Storage ,Drug Administration ,New Drug Application ,Sumitomo Pharma America ,